Screening in asymptomatic SDHx mutation carriers: added value of 18F-FDG PET/CT at initial diagnosis and 1-year follow-up

DEANDREIS, Desiree';
2015-01-01

2015
42
6
868
876
http://link.springer.com/journal/volumesAndIssues/259
18F-FDG PET/CT; Paraganglioma; Phaeochromocytoma; Screening; Succinate dehydrogenase; 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Asymptomatic Diseases; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Pedigree; Pheochromocytoma; Succinate Dehydrogenase; Tomography, X-Ray Computed; Fluorodeoxyglucose F18; Heterozygote; Positron-Emission Tomography; Radiopharmaceuticals; Radiology, Nuclear Medicine and Imaging; Medicine (all)
Lepoutre-Lussey, C; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A.-P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1615201
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 14
social impact